What do systematic reviews say?

Antiplatelet drug vs control

It is very uncertain whether antiplatelet drug changes recurrent ischaemic/unknown stroke during treatment period compared with control (very low certainty).

• Oral antiplatelet therapy for acute ischaemic stroke 2022 · Cochrane Headline outcomes only
  Peto OR 0.79 [0.7, 0.88]
  9 studies · 41652 participants
  Very low